ClinicalTrials.gg
Active, not recruitingNCT04778761Updated Oct 27, 2026

ACP Video Intervention for Patients With Life-Limiting Illness

An interventional study of Home ACP Video in Health Care Utilization and End Stage Disease, sponsored by Massachusetts General Hospital. Active, not recruiting at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 27, 2026Now Active, not recruitingPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 134 studies in Patient Acceptance of Health Care with a site in United States — 24 open to participants now, 35 under way, 1 of them phase 3. Patient Acceptance of Health Care · United States.

Planned enrollment
34th of 109
500 · median 264
Started
2021
with 22 others
No phase
100 of 134
21 open now
Primary completion
2027-03
later than 22 of 34 live
Registered
62nd of 134
by date

Among the 134 studies in Patient Acceptance of Health Care with a site in United States, this one is the 34th largest by planned enrollment of the 109 interventional ones that give a count, is one of 23 that started in 2021, is one of 100 with no phase, reaches primary completion later than 22 of the 34 other live ones, and was the 62nd registered.

Patient Acceptance of Health Care

309 studies on the registry are indexed under Patient Acceptance of Health Care; 54 are open to participants now.

Browse Patient Acceptance of Health Care studies →

Open to participants now

24 of the 134 studies in Patient Acceptance of Health Care with a site in United States are open now. Recruiting first, the newest first:

19 more — sign in →

All 24 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 34 Patient Acceptance of Health Care studies recruiting now, 22 (65%) set no upper age limit and 9 (26%) stop at 75 or younger; 11 take children under 18; 16 take healthy volunteers.

This study: 21 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 134 studies in Patient Acceptance of Health Care with a site in United States, or all of them as a file.
02

Study summary

The goal of this research is to increase patients' knowledge about advance care planning (ACP) discussions and hospice care for patients with serious illness receiving home-based care.

Read the detailed description

ACP is a process that allows patients to communicate their wishes and preferences or medical care, when they are seriously ill, to their medical providers. The study investigators would like to assess whether a home-ACP video can improve patient-clinician communication about patients wishes for their medical care and lead to more patient-centered care.

This study is a randomized clinical trial of a Home-ACP intervention among 500 adult patients with serious illness receiving medical care at home with the Clover Health House Calls Program. Study participants will be assigned to one of two groups. In one group, participants will continue to receive usual care with their home-based care team. In the second group, participants will continue to receive their usual care with their home-based care team and also view an ACP video that helps them understand ACP and provides education about ACP and hospice care.

03

Conditions studied

  • Health Care Utilization
  • End Stage Disease
04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 21 or over
  • Have a one-year prognosis or less as determined by Clover Health's validated algorithm
  • Speak either English or one of the other 25 languages in which the video intervention is available

Exclusion criteria

Exclusion Criteria:

  • Visually impaired beyond 20/200 corrected
  • Acute psychiatric illness or other comorbid condition that impairs cognitive ability to participate in advance care planning discussion as determined by the primary House Call Provider.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
500 participants (estimated)

Study arms

  • No intervention
    Usual Care

    Usual care entails receiving usual medical care by the home-based care team.

  • Experimental
    Video intervention

    In addition to usual care, the intervention will entail having a visit by a trained study clinician to provide access to the ACP video. The study clinician will discuss the content of the video and answer any questions.

    Behavioral: Home ACP Video

Interventions

  • BehavioralHome ACP Video

    A video focused on Advance Care Planning and Hospice for patients with serious illness

06

What researchers measure

Primary outcomes

  1. Hospice utilization

    Compare the use of hospice (yes vs. no) between the study groups

    Time frame: up to one year follow-up or death

Secondary outcomes

  1. Hospice length of stay

    Compare hospice length-of-stay between the study groups

    Time frame: up to one year follow-up or death

  2. Rates of documented resuscitation preferences in the Electronic Health Record

    Compare documented resuscitation preferences in the Electronic Health Record between the two groups

    Time frame: up to one year follow-up or death

  3. Rates of Advance Care Planning documentation in the Electronic Health Record

    Compare advance care planning documentation in the Electronic Health Record between the two groups

    Time frame: up to one year follow-up or death

  4. Patient knowledge about Advance Care Planning

    Compare patient's knowledge about advance care planning using a 5-item knowledge questionnaire (range 0-5), higher score indicate more knowledge

    Time frame: Up to two days following the intervention visit

  5. Patient reported confidence in care

    Compare patient's reported confidence in their medical care using a single Likert response question between the two study groups. Score range from 0-4. Higher scores indicate higher confidence in care

    Time frame: up to two days following the intervention visit

  6. Patient reported satisfaction with clinician communication

    Compare patient satisfaction with their communication with their clinician using the CAHPS subscale. Score range 0-20. Higher score indicate better satisfaction with communication

    Time frame: up to two days following the intervention visit

  7. Patient reported decisional satisfaction

    Compare patient reported decisional satisfaction between the study groups using the Satisfaction with Decision Scale. Scale range from 6-30. Higher scores indicate higher satisfaction with decision

    Time frame: up to two days following the intervention visit

  8. Patient reported decisional certainty

    Compare patient reported decisional certainty between the two groups using the Decision Conflict Scale. Score ranges from 0 to 100. Higher scores indicate higher decisional conflict

    Time frame: up to two days following the intervention visit

Other outcomes

  1. Cost of care in the last year of life

    Compare cost of care in the last year of life between the study groups

    Time frame: 1 year

07

Study locations

1 site
  • Clover Health
    Jersey City, New Jersey 07302, United States
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2021 (actual). Primary completion is estimated for Mar 2027, 71 months after the start.

Of 151 non-industry interventional studies with no phase under Patient Acceptance of Health Care, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 35. This study's planned 71 months is above that.

Counting every sponsor, half of 154 studies reached it within 19 months; a quarter within 8 and three quarters within 34.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 27, 2026: primary completion Dec 2025 → Mar 2027 and completion Dec 2027 → Mar 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2021
First posted
Mar 3, 2021
StartActual
Apr 1, 2021
Primary completionEst.
Mar 1, 2027was Dec 2025
CompletionEst.
Mar 1, 2028was Dec 2027
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Oct 27, 2026
Primary completion
Dec 1, 2025→Mar 1, 2027
Oct 27, 2026
Study completion
Dec 1, 2027→Mar 1, 2028
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Recruiting→Active, not recruiting
    Primary completion Dec 1, 2025→Mar 1, 2027
    Study completion Dec 1, 2027→Mar 1, 2028
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT04778761
Responsible party
El-Jawahri, Areej,M.D. (Assistant Professor Of Medicine, Massachusetts General Hospital) — Principal investigator
First posted
Mar 3, 2021
Start date
Apr 1, 2021
Primary completion
Mar 1, 2027 (estimated)
Completion
Mar 1, 2028 (estimated)
Last update
Oct 27, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion